Purchase Order 75F40121P00340
Award Date 9/15/21
Potential Completion Date 9/29/22
Potential Value $20K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
Total Small Business
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Silver Spring, MD 20993, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This firm fixed price purchase order contract was awarded by the National Cancer Institute, a civilian agency within the Department of Health and Human Services, to Sentieon, Inc. for $18,000.00. Sentieon, Inc. is a self-certified small disadvantaged business that develops and supplies bioinformatics secondary analysis tools for processing genomics data. The contract is for the provision of Sentieon's proprietary software and licenses to support whole genome sequencing efforts at the National...
- Sentieon Inc. was awarded a $12,000 firm fixed price purchase order by the National Cancer Institute (NCI), a component of the National Institutes of Health within the Department of Health and Human Services. The proprietary software acquired under this contract will support whole genome sequencing for the Never Smokers Study being conducted by NCI. Sentieon, located in San Jose, California, will serve as the prime contractor to deliver its proprietary software solution from September 1, 2023...
- The Food and Drug Administration awarded a $22.9K firm fixed-price purchase order to Pacific Biosciences of California, Inc., a Menlo Park-based biotechnology manufacturer specializing in advanced DNA and RNA sequencing technologies. The award, designated as a total small business set-aside, was executed on July 27, 2021, for SMRT cell 8M trays and Sequel II sequencing kits—consumable products essential for next-generation sequencing operations. The procurement was completed ahead of the October...
- The Food and Drug Administration (FDA) awarded a $22,067 firm fixed-price purchase order to 10X Genomics, Inc. for single cell sequencing library supplies. The contract, designated as a total small business set-aside, was awarded on July 26, 2019, with an ultimate completion date of August 25, 2019. Performance is to take place at 10X Genomics' headquarters in Pleasanton, California. This procurement reflects the FDA's need for advanced genomic analysis capabilities, specifically single-cell...
- This is a $40,227.00 firm-fixed-price purchase order awarded by the Food and Drug Administration (FDA), a civilian federal agency, to Government Scientific Source Inc., a for-profit organization based in Reston, Virginia. The objective of this purchase order is to acquire whole genome sequencing services. The contract has an ultimate completion date of September 18, 2026 and was awarded on September 12, 2025. This purchase order is not associated with a set-aside program. Government Scientific...
- This contract award to Pacific Biosciences of California, Inc., a small business manufacturer, is for the provision of high-throughput, long-read DNA sequencing systems and associated consumables to the U.S. Food and Drug Administration (FDA). The $83,644 firm fixed-price purchase order has an ultimate completion date of October 14, 2015. Pacific Biosciences is the original equipment manufacturer for their proprietary single molecule, real-time (SMRT) sequencing technology, which is utilized...
- The Department of Health and Human Services Food and Drug Administration awarded a $51,193.93 purchase order to Pacific Biosciences of California, Inc. for sequencing supplies. The firm fixed price contract runs from August 23, 2023 to February 19, 2024 and will be performed by Pacific Biosciences in West Menlo Park, California. The original solicitation sought sequencing supplies as described in Combined Synopsis Solicitation 75F40123Q-117934 to support the FDA's evaluation of new sequencing...
- The National Cancer Institute (NCI) awarded a $20,000 firm fixed-price purchase order to Sentieon Inc. on March 20, 2026, to renew an annual software license subscription for one year through March 19, 2027. This contract, which carries no set-aside designation, supports the NCI's genomic research capabilities by providing continued access to Sentieon's proprietary bioinformatics and genomic data analysis software. The work will be performed at the NCI's location in Bethesda, Maryland....
- This is a $99,900 firm-fixed price purchase order awarded by the Food and Drug Administration (FDA) to Seqmatic, LLC, a minority-owned, Asian-Pacific American-owned small business based in Fremont, California. The contract is for the purchase of next-generation sequencing (NGS) RNA reagents tests, with a period of performance through September 7, 2026. The contract was awarded under a full and open solicitation, with no set-aside designation. Seqmatic will perform bulk RNA transcriptomics...
- The Food and Drug Administration awarded a $52.6K delivery order to Government Scientific Source Inc. for 10X Genomics single-cell RNA sequencing consumables. This firm fixed price contract, issued on July 3, 2019, with an ultimate completion date of September 3, 2019, was performed in Herndon, Virginia. The award was not issued under a set-aside designation and was executed through the General Services Administration's Scientific Equipment and Services Multiple Award Schedule (FSS-66), a...